Financials · Insurance Agents, Brokers & Service

MRSH Marsh McLennan SEC Filings & Insider Trading Activity 2026

company
CIK 62709122 filings
S&P 500

MRSH at a glance

Marsh McLennan (MRSH, SEC CIK 62709) filed its latest 10-K annual report on February 9, 2026, a 10-Q quarterly report on October 15, 2026, an 8-K current report on October 27, 2026 and Form 4 insider filings as recently as November 17, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Marsh McLennan (MRSH) reported revenue of $27.0 billion (up 10.3% from FY2024) and net income of $4.2 billion. Diluted EPS was $8.43.
  • As of September 30, 2026, 46 institutional investment managers tracked by SignalX reported holding Marsh McLennan (MRSH) shares worth $29.0 billion in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Fernandez Carmen on November 16, 2026 of 3,598 shares at $211.38 per share.
  • In the last 90 days, MRSH insiders reported 0 open-market purchases ($0) and 7 open-market sales ($5.5M) on Form 4, a net sale of $5.5M.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$27.0B
+10.3% vs prior year
Insiders · 90 days
0 buys · 7 sells
Net −$5.5M
13F holders
46 funds
$29.0B · +1 vs prior quarter
Latest 8-K
Oct 27, 2026
Item 8.01

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Risk Factors

  • Regulatory risk: Compliance costs and penalties under GDPR, CCPA, emerging EU AI Act impacting financial condition and reputation
  • Geopolitical threat: Exposure to conflict zones including Ukraine war, Middle East tensions, and Latin America impacting economic markets and client demand
  • Operational vulnerability: Reliance on third-party vendors and introducers may cause harm if these parties fail or act improperly
  • Market disruption: Competitive pressures including disintermediation and evolving landscape threatening growth in Risk and Insurance Services
  • Financial risk: Significant uninsured exposures from errors and omissions and breach of fiduciary duty claims with potential for material losses

Management Discussion & Analysis

  • Revenue $27.0B, up 10% YoY ($2.5B increase), underlying growth 4%; Risk & Insurance Services +12%, Consulting +7%
  • Operating income $6.2B, up 7% YoY; Risk & Insurance margin 26.8% down from 28.4%, Consulting margin flat at 19.4%
  • Best segment: Risk & Insurance Services revenue $17.3B (+12%), operating income $4.6B; Worst: Corporate expenses $309M (-3%), net loss segment
  • Cash flow: repaid $500M senior notes; share repurchases $2.0B (10.1M shares); dividends paid $1.7B; $857M spent on 20 acquisitions
  • Outlook/risks: macro/geopolitical conflicts, trade policies, slower GDP, FX volatility, inflation, insurance premium rate changes could impact future results

Business Overview

  • Core business model focused on risk management and consulting services (implied from company identity, no new business model details given)
  • No new products, services, or segments introduced or emphasized in the 2026 filing text provided
  • Emphasis on updated insider trading policies and compliance protocols with detailed Trading Securities Policy enhancements
  • Referenced policies filed as Exhibits 19.1 and 19.2 to the 10-K, reflecting formalized governance and compliance documentation
  • Heavy reliance on cross-references to 2026 Proxy Statement for compensation, stock ownership, and governance information

AI summary of the MRSH 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • No risk-factors section provided, preventing identification of new or changed risks since the 10-K
  • Debt balance increased to $20,533 million from $19,587 million at December 31, 2025
  • Cash and cash equivalents declined to $1,842 million from $2,687 million at December 31, 2025
  • Accumulated other comprehensive loss widened to $5,514 million from $5,429 million at December 31, 2025

Management Discussion & Analysis

  • Revenue $6.863B, up 8% from $6.351B YoY, with underlying growth of 5%
  • Operating margin 17.7% vs 18.4% YoY, pressured by Greensill settlement and higher expenses
  • Best performer: Management Consulting revenue $1.013B, up 14%; weakest: Reinsurance revenue $374M, down 6%
  • Operating cash flow $2.3B vs $3.1B YoY; share repurchases $500M and acquisitions $263M
  • Program cost estimate increased to approximately $750M, with expected annualized savings of approximately $600M; headwinds include declining premium rates and macro volatility

AI summary of the MRSH 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Oct 27, 2026Full analysis →

Item 8.01: Other Events

  • €1.2B senior-note issuance completed October 27, 2026, increasing Marsh McLennan’s debt funding
  • €600M 4.250% notes mature 2032, implying €25.5M annual coupon obligations
Filed Oct 15, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Third-quarter results for period ended September 30, 2026, released October 15, 2026
  • Conference call scheduled October 15, 2026 at 8:30 a.m. Eastern time

Item EX-99.1: Item EX-99.1

  • Q3 revenue $6.9B, up 8%, with underlying growth 5%, signaling solid organic demand
  • Adjusted EPS $2.03, up 10%, while GAAP EPS reached $1.69
Filed Jul 21, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q2 2026 results for quarter ended June 30, 2026 released July 21, 2026
  • Conference call scheduled for 8:30 a.m. Eastern time on July 21, 2026

Item EX-99.1: Item EX-99.1

  • Q2 revenue $7.4B, up 6%; underlying growth 5%, indicating broad-based organic expansion
  • Adjusted EPS $2.96, up 9%; GAAP EPS $2.63, with restructuring and litigation adjustments material

AI summaries of MRSH 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for MRSH

Don't miss the next MRSH filing

  • Alerts as it files. A push when MRSH files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut MRSH, by share count.
  • Ask anything. An AI agent that reads every MRSH filing and answers with sources.

MRSH alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Fernandez CarmenSellNov 16, 2026$211.38
Fernandez CarmenMNov 16, 2026$90.78
Fernandez CarmenMNov 16, 2026-
Fernandez CarmenMNov 16, 2026-
Anderson AnthonySellNov 16, 2026$210.52
Fernandez CarmenMNov 16, 2026$83.05
SCHAPIRO MORTON OANov 15, 2026$208.32
Yates Lloyd MANov 15, 2026$208.32

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$24.5B$27.0B
Operating Income-$5.8B$6.2B
Net Income$3.8B$4.1B$4.2B
Op. Margin-23.8%23.1%
Net Margin-16.6%15.4%
Balance Sheet
Total Assets$48.0B$56.5B$58.7B
Equity-$13.5B$15.3B
ROE-30.0%27.2%
Per Share
EPS$7.53$8.18$8.43
Cash Flow
Operating CF-$4.3B$5.3B
CapEx$416.0M$316.0M$291.0M

Source: XBRL data in Marsh McLennan (MRSH)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate MRSH share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
MRSH shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202646$29.00B
Q2 202645$29.54B
Q1 202648$32.18B
Q4 202549$34.70B
Q3 202551$39.32B
Q2 202547$42.51B
Q1 202549$35.46B
Q4 202440$25.71B
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 375 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

MRSH filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 17, 2026--
4Nov 17, 2026--
4Nov 17, 2026--
4Nov 17, 2026--
4Nov 17, 2026--
4Nov 17, 2026--
4Nov 17, 2026--
4Nov 17, 2026--
4Nov 17, 2026--
4Nov 17, 2026--
4Nov 9, 2026--
4Nov 4, 2026--
8-KOct 27, 2026Analysis-
4Oct 26, 2026--
4Oct 26, 2026--
8-KOct 15, 2026Analysis-
10-QOct 15, 2026Analysis
4Sep 3, 2026--
4Sep 3, 2026--
4Aug 18, 2026--
4Aug 18, 2026--
4Aug 18, 2026--
4Aug 18, 2026--
4Aug 18, 2026--
4Aug 18, 2026--

Related Financials companies

All Financials →

MRSH SEC filings: frequently asked questions

Are MRSH insiders buying or selling?

In the last 90 days, Marsh McLennan (MRSH) officers, directors and 10% owners reported no open-market purchases and 7 open-market sales worth $5.5 million by 7 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold MRSH stock?

As of September 30, 2026, the largest Marsh McLennan (MRSH) holders among the 13F filers tracked by SignalX were BlackRock ($6.7 billion), Vanguard Capital Management LLC ($5.3 billion), State Street Corp ($3.8 billion), T. Rowe Price Group ($2.4 billion), Vanguard Portfolio Management LLC ($2.1 billion). 13F-HR reports are filed up to 45 days after each quarter ends.

What was MRSH's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Marsh McLennan (MRSH) reported revenue of $27.0 billion (up 10.3% from FY2024) and net income of $4.2 billion. Diluted EPS was $8.43. The figures come from the XBRL data in the 10-K.

What are the main risks in MRSH's latest 10-K?

In the 10-K filed February 9, 2026, Marsh McLennan (MRSH) flagged: Regulatory risk: Compliance costs and penalties under GDPR, CCPA, emerging EU AI Act impacting financial condition and reputation. Geopolitical threat: Exposure to conflict zones including Ukraine war, Middle East tensions, and Latin America impacting economic markets and client demand. (AI summary of the Risk Factors section.)

What did MRSH report in its latest 8-K?

Marsh McLennan (MRSH) filed an 8-K on October 27, 2026 reporting Item 8.01 (Other Events). €1.2B senior-note issuance completed October 27, 2026, increasing Marsh McLennan’s debt funding.

What are the latest MRSH SEC filings?

Marsh McLennan (MRSH) filed its latest 10-K annual report on February 9, 2026, a 10-Q quarterly report on October 15, 2026, an 8-K current report on October 27, 2026 and a Form 4 insider filing on November 17, 2026.

What is MRSH's SEC CIK number?

Marsh McLennan (MRSH)'s SEC Central Index Key (CIK) is 62709. EDGAR lists every MRSH filing under that number.

Ask anything about MRSH

The research agent reads MRSH's filings, financials, insider trades and 13F holders, then answers with sources.